Table 4.
Biomarkers
|
|
|||
Traditional biomarkers | Traditional biomarkers of glomerular injury | Albumin/creatinine ratio eGFR | Lack of specificity and sensitivity | (1) Predict the late stages of DKD; (2) Daily variation in urine albumin/creatinine ratio; and (3) eGFR values may be affected by the patient’s hemodynamics, diet and hydration status |
Novel biomarkers | Glomerular biomarkers | NF-α, transferrin, Type IV collagen, L-PGDS, IgG, ceruloplasmin, laminin, GAGs, fibronectin, podocalyxin, VEGF | Appear before microalbuminuria | Early predictor of DKD |
Tubular biomarkers | α-1-microglobulin CysC; KIM-1; NGAL; nephrin; NAG; L-FABP; VDBP; CypA; s-Klotho | Appear before/precede microalbuminuria | (1) Are more sensitive vs new glomerular biomarkers; (2) Early predictors of DKD; and (3) Predictor of DKD progression | |
Biomarkers of inflammation | Cytokines: TNF-α, IL-1β, IL-18, interferon gamma-IP-10, MCP-1, adiponectin, G-CSF, eotaxins, RANTES or CCL-5, orosomucoid | (1) Precede a significantly increased albuminuria; (2) Correlate positively with albumin excretion rate and intima-media thickness; and (3) May trigger direct renal injury | Predictor of DKD progression | |
Biomarkers of oxidative stress | Urinary 8oHdG Pentosidine | Predict the development of DKD |
L-PGDS: Lipocalin-type prostaglandin D synthase; IgG: Immunoglobulin G; GAGs: Glycosaminoglycans; CysC: Cystatin C; KIM-1: Kidney injury molecule 1; 8oHdG: 8-oxo-7,8-dihydro-2-deoxyguanosine; RANTES: Regulated on activation, normal T cell expressed and secreted; G-CSF: Granulocyte colony-stimulating factor; MCP-1: Monocyte chemoattractant protein 1; IP-10: Induced protein-10; TNF-α: Tumor necrosis factor α; IL: Interleukin; CypA: Cyclophilin A; VDBP: Vitamin D-binding protein; L-FABP: Liver-type fatty-acid binding protein; NAG: N-acetyl-β-D-glucosaminidase; NGAL: Neutrophil gelatinase-associated lipocalin; DKD: Diabetic kidney disease; eGFR: Estimated glomerular filtration rate; VEGF: Vascular endothelial growth factor; CCL-5: Chemokine ligand 5T.